Top Markets
Coin of the day
Faeth Therapeutics, Inc. Faeth Therapeutics, Inc.

Faeth Therapeutics, Inc.

FTH
Rank in Stocks #26773
Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on... Faeth Therapeutics, Inc. is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. [28, 70] The company's lead program, PIKTOR, is an investigational all-oral combination therapy targeting the PI3K/AKT/mTOR pathway. [28, 70]
Share Price
$28.27
Last synced: 2026-08-11
Market Cap
$37.93M
Change (1 day)
-1.07%
Change (1 year)
255.09%
Country
US
Trade Faeth Therapeutics, Inc. (FTH)

Category

Earnings for Faeth Therapeutics, Inc. (FTH)
Earnings in 2026 TTM: 0
According to Faeth Therapeutics, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Faeth Therapeutics, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
$5.27B -
US
$1.95B -
NL
$1.61B -
AU
$-3.09B -
US
- -
CH